Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4170126 | 0.95 | CYP1A2 (0.42) | CYP1A2NAAAHTTLMNAMAPK1 | |
| SCHEMBL504003 | 0.94 | CYP1A2 (0.41) | CYP1A2NAAAHTTLMNAMAPK1 | |
| SCHEMBL5862504 | 0.93 | HTT (0.40) | CYP1A2NAAAHTTLMNAMAPK1 | |
| SCHEMBL1896640 | 0.93 | HTT (0.40) | CYP1A2NAAAHTTLMNAMAPK1 | |
| SCHEMBL11290481 | 0.93 | HTT (0.40) | CYP1A2NAAAHTTLMNAMAPK1 | |
| SCHEMBL8975284 | 0.93 | HTT (0.40) | CYP1A2NAAAHTTLMNAMAPK1 | |
| SCHEMBL8735525 | 0.91 | CYP1A2 (0.36) | CYP1A2NAAAHTTLMNAMAPK1 | |
| SCHEMBL4159832 | 0.90 | CYP1A2 (0.37) | CYP1A2NAAAHTTLMNAMAPK1 | |
| SCHEMBL6278928 | 0.88 | HPGD (0.34) | CYP1A2NAAALMNAMAPTHPGD | |
| SCHEMBL7723142 | 0.87 | CYP1A2 (0.35) | CYP1A2NAAAHTTLMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118702646-A | Novel polymerizable liquid crystal | 罗利克技术有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-114026078-B | Novel polymerizable liquid crystal | 罗利克技术有限公司 | 2024-06-07 | — | — | CN | disclosed |
| EP-3191088-B1 | AN ANTICONVULSANT COMPOUND | ROYAL HOLLOWAY & BEDFORD NEW COLLEGE (GB) | 2020-12-16 | — | — | EP | disclosed |
| US-10301263-B2 | Anticonvulsant compound | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2019-05-28 | — | — | US | disclosed |
| US-20170305859-A1 | An Anticonvulsant Compound | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2017-10-26 | — | — | US | disclosed |
| EP-3191088-A1 | AN ANTICONVULSANT COMPOUND | Royal Holloway And Bedford New College (GB) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016038379-A1 | AN ANTICONVULSANT COMPOUND | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2016-03-17 | — | — | WO | disclosed |
| EP-2319882-B1 | POLYOLEFIN RESIN COMPOSITION | ADEKA CORP (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-8288462-B2 | Polyolefin resin composition | ADEKA CORPORATION (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20110218279-A1 | POLYOLEFIN RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2011-09-08 | — | — | US | disclosed |
| US-20050104036-A1 | Composite liquid crystalline mixture | PHOTINTECH INC. (CA) | 2005-05-19 | — | — | US | disclosed |
| US-20030144338-A1 | Tyrosine phosphatase inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-07-31 | — | — | US | disclosed |
| EP-1284260-A1 | TYROSINE PHOSPHATASE INHIBITORS | Takeda Chemical Industries, Ltd. (JP) | 2003-02-19 | — | — | EP | disclosed |
| US-20030031862-A1 | Adhesive sheet for dicing | NITTO DENKO CORPORATION (JP) | 2003-02-13 | — | — | US | disclosed |
| EP-1270696-A2 | Adhesive sheet for dicing | NITTO DENKO CORPORATION (JP) | 2003-01-02 | — | — | EP | disclosed |
| US-5762824-A | VISUAL AIDS WITH QUINOPHTHALONE PIGMENTS WITH DIELECTRIC ANISOTROPY | CHISSO CORPORATION (JP) | 1998-06-09 | — | — | US | disclosed |
| US-5354502-A | Very large dielectric anisotropy and small birefringence | SEIKO EPSON CORPORATION (JP) | 1994-10-11 | — | — | US | disclosed |
| US-5238599-A | Low threshold voltage, low driving voltage | SEIKO EPSON CORPORATION (JP) | 1993-08-24 | — | — | US | disclosed |
| EP-0447565-A1 | 1,3-DIOXANE DERIVATIVE AND LIQUID-CRYSTAL COMPOSITION CONTAINING THE SAME | SEIKO EPSON CORPORATION (JP) | 1991-09-25 | — | — | EP | disclosed |
| EP-0400861-A1 | 1,3-dioxane derivative and liquid crystal composition incorporating the same | SEIKO EPSON CORPORATION (JP) | 1990-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144338-A1 | Tyrosine phosphatase inhibitors | PTPRC, PTPN1, PTPRM | CYP1A2 2824/4885NAAA 4771/4885HTT 4693/4885 |
| US-20170305859-A1 | An Anticonvulsant Compound | PSEN2, BACE2, APP | CYP1A2 279/4885NAAA 525/4885HTT 453/4885 |
| US-10301263-B2 | Anticonvulsant compound | PSEN2, BACE2, APP | CYP1A2 230/4885NAAA 545/4885HTT 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.